The effects of acute and chronic amiodarone on activation patterns and defibrillation threshold during ventricular fibrillation in dogs

Journal of the American College of Cardiology

Volumn 40, Issue 2, 2002, Pages 375-383

  Huang, Jian ^a,d   Skinner, Jonathan L ^b   Rogers, Jack M ^c   Smith, William M ^c   Holman, William L ^b   Ideker, Raymond E ^a,c,d  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

^c and Radiation Oncology   (United States)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DOG; DRUG EXPOSURE; DRUG MECHANISM; ELECTRODE; FRACTIONATION; HEART CONDUCTION; HEART CYCLE; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE FIBRILLATION; NONHUMAN; PRIORITY JOURNAL; REENTRY ARRHYTHMIA;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOGS; ELECTRIC COUNTERSHOCK; RESEARCH DESIGN; VENTRICULAR FIBRILLATION;

EID: 0037125370     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01942-3     Document Type: Article

References (44)

1. Amiodarone: Historical development and pharmacologic profile
2. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation
3. Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold
4. Effects of long-term amiodarone treatment on ventricular-fibrillation vulnerability and defibrillation efficacy in response to monophasic and biphasic shocks
5. Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements
6. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation: Importance of use-dependent effects on refractoriness
7. Length of excitation wave and susceptibility to re-entrant atrial arrhythmias in normal conscious dogs
8. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: Antiarrhythmic and proarrhythmic effects
9. Incidence, evolution and spatial distribution of functional re-enthy during ventricular fibrillation in pigs
10. Evolution of the organization of epicardial activation patterns during ventricular fibrillation
11. Fibrillation is more complex in the left ventricle than in the right ventricle
12. Improvement of defibrillation efficacy and quantification of activation patterns during ventricular fibrillation in a canine heart failure model
13. AHA Special Report. Position of the American Heart Association on research animal use
14. Dispersion of refractoriness in canine ventricular myocardium: Effects of sympathetic stimulation
15. Effects of intravenous amiodarone on electrical dispersion in normal and ischaemic tissues and on arrhythmia inducibility: Monophasic action potential studies
16. Analysis of amiodarone and desethylamiodarone in serum and tears by reversed-phase high-performance liquid chromatography
17. A quantitative framework for analyzing epicardial activation patterns during ventricular fibrillation
18. Recurrent wavefront morphologies: A method for quantifying the complexity of epicardial activation patterns
19. Relation between amiodarone and desethylamiodarone plasma concentrations and ventricular defibrillation energy requirements
20. Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment
21. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: Interactions with acute sotalol
22. Myocardial disposition of amiodarone in the dog
23. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model
24. Antiarrhythmic actions of amiodarone: A profile of a paradoxical agent
25. Electrophysiological deterioration during long-duration ventricular fibrillation
26. Acute and chronic effects of amiodarone on delayed after depolarization and triggered automaticity in rabbit ventricular myocardium
27. Effects of amiodarone on barium-induced automatic activity in guinea pig ventricular muscle
28. Amiodarone reduces transmural heterogeneity of repolarization in the human heart
29. Chronic amiodarone reduces transmural dispersion of repolarizatlon in the canine heart
30. Effects of amiodarone on wavefront dynamics during ventrlcular fibrillation in isolated swine right ventricle
31. Chaos and the transition to ventricular fibrillation: A new approach to antiarrhythmic drug evaluation
32. Electrical alternans and spiral wave breakup in cardiac tissue
33. Spatiotemporal transition to conduction block in canine ventricle
34. Ventricular fibrillation is not always due to multiple wavelet re-entry
35. High-frequency periodic sources underlie ventricular fibrillation in the isolated rabbit heart
36. Re-entrant wavefronts in Wiggers' stage II ventricular fibrillation
37. Flow of "injury" current and patterns of excitation during early ventricular arrhythmias in acute regional myocardial ischemia in isolated porcine and canine hearts: Evidence for two different arrhythmogenic mechanisms
38. Mechanisms underlying the development of ventricular fibrillation during early myocardial ischemia
39. Alteration of ventricular fibrillation bv flecainide, verapamil, and sotalol: An experimental study
40. Effects of procainamide on wave-front dynamics during ventricular fibrillation in open-chest dogs
41. Polymorphic ventricular tachycardia induced by programmed stimulation: Response to procainamide
42. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol
43. + current
44. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis